| Product Code: ETC10123028 | Publication Date: Sep 2024 | Updated Date: Dec 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The import shipments of non-alcoholic steatohepatitis (NASH) biomarkers to Zambia in 2024 were primarily sourced from key countries such as South Africa, India, Canada, USA, and Czech Republic. The market concentration, as measured by the Herfindahl-Hirschman Index (HHI), remained very high in 2024, indicating a significant level of dominance by these top exporting countries. However, the industry experienced a notable decline in growth, with a compound annual growth rate (CAGR) of -57.5% from 2020 to 2024 and a growth rate of -46.72% from 2023 to 2024. These trends suggest a challenging environment for the NASH biomarkers

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Zambia Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Overview |
3.1 Zambia Country Macro Economic Indicators |
3.2 Zambia Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, 2021 & 2031F |
3.3 Zambia Non-alcoholic Steatohepatitis (NASH) Biomarkers Market - Industry Life Cycle |
3.4 Zambia Non-alcoholic Steatohepatitis (NASH) Biomarkers Market - Porter's Five Forces |
3.5 Zambia Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume Share, By Biomarker Type, 2021 & 2031F |
3.6 Zambia Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Zambia Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of non-alcoholic steatohepatitis (NASH) in Zambia |
4.2.2 Rising awareness about the importance of early diagnosis and treatment of NASH |
4.2.3 Advancements in medical technology leading to better diagnostic capabilities |
4.3 Market Restraints |
4.3.1 Lack of skilled healthcare professionals for accurate diagnosis and monitoring of NASH |
4.3.2 Limited access to advanced diagnostic tools and technologies in certain regions of Zambia |
5 Zambia Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Trends |
6 Zambia Non-alcoholic Steatohepatitis (NASH) Biomarkers Market, By Types |
6.1 Zambia Non-alcoholic Steatohepatitis (NASH) Biomarkers Market, By Biomarker Type |
6.1.1 Overview and Analysis |
6.1.2 Zambia Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, By Biomarker Type, 2021- 2031F |
6.1.3 Zambia Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, By Serum Biomarkers, 2021- 2031F |
6.1.4 Zambia Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, By Biomarker Panels, 2021- 2031F |
6.1.5 Zambia Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, By Fibrosis Biomarkers, 2021- 2031F |
6.1.6 Zambia Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, By Imaging Biomarkers, 2021- 2031F |
6.1.7 Zambia Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Zambia Non-alcoholic Steatohepatitis (NASH) Biomarkers Market, By End User |
6.2.1 Overview and Analysis |
6.2.2 Zambia Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.2.3 Zambia Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, By Diagnostic Centers, 2021- 2031F |
6.2.4 Zambia Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, By Others, 2021- 2031F |
7 Zambia Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Import-Export Trade Statistics |
7.1 Zambia Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Export to Major Countries |
7.2 Zambia Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Imports from Major Countries |
8 Zambia Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Key Performance Indicators |
8.1 Number of healthcare facilities offering NASH biomarker testing in Zambia |
8.2 Rate of adoption of NASH biomarker testing by healthcare providers |
8.3 Patient awareness levels about NASH biomarker testing and its benefits |
9 Zambia Non-alcoholic Steatohepatitis (NASH) Biomarkers Market - Opportunity Assessment |
9.1 Zambia Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Opportunity Assessment, By Biomarker Type, 2021 & 2031F |
9.2 Zambia Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Zambia Non-alcoholic Steatohepatitis (NASH) Biomarkers Market - Competitive Landscape |
10.1 Zambia Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenue Share, By Companies, 2024 |
10.2 Zambia Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |